← All organizations

IBSA Institut Biochimique SA

For profitWebsite ↗

Also known as: IBSA | IBSA Farmaceutici Italia Srl | IBSA Head of R&D Scientific Affairs | IBSA INST BIO | IBSA Institut Biochimique SA | INST BIOCHEM | INST BIOCHIMIQUE SA | INSTITUT BIOCHIMIQUE

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Dec 16, 2025

Timeline

1940s

Jan 1, 1945
IBSA Institut Biochimique SA— Founded

2000s

Oct 13, 2006
levothyroxine— NDA Secondary Org
Oct 13, 2006
levothyroxine— Marketing Organization

Drugs by trial phase (20 distinct, 35 trials)

Phase 4 (8 own, 0 via acquisition)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

selenomethionine se-75

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (4)

Recent trials (38)

NCT05989984Lead sponsorN/AAug 4, 2023
NCT05936346Lead sponsorN/AJul 17, 2023
NCT05632783Lead sponsorPhase 3Apr 30, 2023
NCT05490680Study directorPhase 3Nov 30, 2022
NCT05490680Lead sponsorPhase 3Nov 30, 2022
NCT05660200Lead sponsorN/ANov 25, 2022
NCT05652374CollaboratorPhase 4Oct 20, 2022
NCT05228184Study directorPhase 4Dec 17, 2021
NCT05228184Lead sponsorPhase 4Dec 17, 2021
NCT05171673Lead sponsorPhase 3Oct 31, 2021
NCT04549116Lead sponsorPhase 3Nov 30, 2020
NCT04095572CollaboratorPhase 4Oct 27, 2020
NCT04365127CollaboratorPhase 1Apr 27, 2020
NCT03701490Lead sponsorPhase 2Feb 19, 2019
NCT03735030Lead sponsorPhase 1Nov 27, 2018

Details

Founded: Lugano, CH Jan 1, 1945
Last known activity: Dec 16, 2025